Scarica l'app Stockscreener
75.51
0.55%
-0.42
Pre-mercato:
76.24
0.73
+0.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$75.93
Aprire:
$75.18
Volume 24 ore:
11.90M
Relative Volume:
1.16
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.35%
1M Prestazione:
-13.33%
6M Prestazione:
-23.07%
1 anno Prestazione:
-8.84%
Intervallo 1D:
$74.67
$77.32
Intervallo di 1 settimana:
$73.94
$77.56
Portata 52W:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Nome
Spdr Biotech Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta XBI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
75.51 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
252.60 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
513.88 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
516.38 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
202.27 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
433.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Borsa (XBI) Ultime notizie
Alliancebernstein L.P. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
O Shaughnessy Asset Management LLC Has $65,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech stocks to own amid market volatility – Piper Sandler (XBI:NYSEARCA) - Seeking Alpha
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets - Yahoo Finance
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
How the (XBI) price action is used to our Advantage - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
11 Stocks to Buy After the Biotech Bloodbath - Barron's
Wednesday's ETF Movers: XBI, PICK - Nasdaq
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies - MSN
XBI Crosses Critical Technical Indicator - Nasdaq
Analysts at Cantor, formerly headed by Lutnick, call for Kennedy's dismissal - Reuters
Biotech stocks plunge as FDA’s Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard - TradingView
Bank of New York Mellon Corp Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Trump administration cancels $12 billion in funding to state health departments (XBI:NYSEARCA) - Seeking Alpha
Proficio Capital Partners LLC Buys 5,225 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Sequoia Financial Advisors LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
How Is Biogen's Stock Performance Compared to Other Biotech Stocks? - TradingView
(XBI) Investment Report - Stock Traders Daily
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Armenian Reporter
Assetmark Inc. Sells 588,528 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Atria Investments Inc Buys 1,043 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
2Seventy Bio (TSVT): Surge Following Acquisition Announcement - Value The Markets
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE - Defense World
Form 424B2 MORGAN STANLEY - StreetInsider.com
Steward Partners Investment Advisory LLC Sells 814 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
(XBI) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Guarantor: JPMorgan Chase & Co. - StreetInsider.com
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Top-rated biotechs with negative enterprise values - MSN
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
Van ECK Associates Corp Makes New $1.50 Million Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Vontobel Holding Ltd. Has $621,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Allspring Global Investments Holdings LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Mirae Asset Global Investments Co. Ltd. Has $299,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
How to Take Advantage of moves in (XBI) - Stock Traders Daily
Unlocking the Mystery of Smart Beta: A Deep Dive into the iShares Biotechnology ETF - Clinique Bio
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - TradingView
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Can Health Care ETFs Aid Your Portfolio? - ETF Trends
Spdr Biotech Etf Azioni (XBI) Dati Finanziari
Non sono disponibili dati finanziari per Spdr Biotech Etf (XBI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):